Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46


Corrigendum: A Comprehensive Analysis of the T and B Lymphocytes Repertoire Shaped by HIV Vaccines.

Wang L, Zhang W, Lin L, Li X, Saksena NK, Wu J, Wang S, Joyce JG, Zhang X, Yang H, Wang J, Wang IM, Liu X.

Front Immunol. 2018 Dec 14;9:2931. doi: 10.3389/fimmu.2018.02931. eCollection 2018.


A Comprehensive Analysis of the T and B Lymphocytes Repertoire Shaped by HIV Vaccines.

Wang L, Zhang W, Lin L, Li X, Saksena NK, Wu J, Wang S, Joyce JG, Zhang X, Yang H, Wang J, Wang IM, Liu X.

Front Immunol. 2018 Sep 26;9:2194. doi: 10.3389/fimmu.2018.02194. eCollection 2018. Erratum in: Front Immunol. 2018 Dec 14;9:2931.


Spectroscopic analysis of chlamydial major outer membrane protein in support of structure elucidation.

Hepler RW, Nahas DD, Lucas B, Kaufhold R, Flynn JA, Galli JD, Swoyer R, Wagner JM, Espeseth AS, Joyce JG, Cook JC, Durr E.

Protein Sci. 2018 Nov;27(11):1923-1941. doi: 10.1002/pro.3501.


Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies.

Kesavardhana S, Das R, Citron M, Datta R, Ecto L, Srilatha NS, DiStefano D, Swoyer R, Joyce JG, Dutta S, LaBranche CC, Montefiori DC, Flynn JA, Varadarajan R.

J Biol Chem. 2017 Jan 6;292(1):278-291. doi: 10.1074/jbc.M116.725614. Epub 2016 Nov 22.


Design and Purification of Subunit Vaccines for Prevention of Clostridium difficile Infection.

Karczewski J, Bodmer JL, Cook JC, Xoconostle RF, Nahas DD, Joyce JG, Heinrichs JH, Secore S.

Methods Mol Biol. 2016;1403:385-96. doi: 10.1007/978-1-4939-3387-7_20.


Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells.

Meng W, Li L, Xiong W, Fan X, Deng H, Bett AJ, Chen Z, Tang A, Cox KS, Joyce JG, Freed DC, Thoryk E, Fu TM, Casimiro DR, Zhang N, A Vora K, An Z.

MAbs. 2015;7(4):707-18. doi: 10.1080/19420862.2015.1051440.


Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.

Karczewski J, Zorman J, Wang S, Miezeiewski M, Xie J, Soring K, Petrescu I, Rogers I, Thiriot DS, Cook JC, Chamberlin M, Xoconostle RF, Nahas DD, Joyce JG, Bodmer JL, Heinrichs JH, Secore S.

Vaccine. 2014 May 19;32(24):2812-8. doi: 10.1016/j.vaccine.2014.02.026. Epub 2014 Mar 21.


Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197.

Caro-Aguilar I, Ottinger E, Hepler RW, Nahas DD, Wu C, Good MF, Batzloff M, Joyce JG, Heinrichs JH, Skinner JM.

Hum Vaccin Immunother. 2013 Mar;9(3):488-96. Epub 2012 Dec 18.


Small molecule mimetics of an HIV-1 gp41 fusion intermediate as vaccine leads.

Caulfield MJ, Dudkin VY, Ottinger EA, Getty KL, Zuck PD, Kaufhold RM, Hepler RW, McGaughey GB, Citron M, Hrin RC, Wang YJ, Miller MD, Joyce JG.

J Biol Chem. 2010 Dec 24;285(52):40604-11. doi: 10.1074/jbc.M110.172197. Epub 2010 Oct 13.


Pushing the envelope on HIV-1 neutralization.

Joyce JG, ter Meulen J.

Nat Biotechnol. 2010 Sep;28(9):929-31. doi: 10.1038/nbt0910-929. No abstract available.


Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge.

Bommakanti G, Citron MP, Hepler RW, Callahan C, Heidecker GJ, Najar TA, Lu X, Joyce JG, Shiver JW, Casimiro DR, ter Meulen J, Liang X, Varadarajan R.

Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13701-6. doi: 10.1073/pnas.1007465107. Epub 2010 Jul 6.


Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates.

Bianchi E, Joyce JG, Miller MD, Finnefrock AC, Liang X, Finotto M, Ingallinella P, McKenna P, Citron M, Ottinger E, Hepler RW, Hrin R, Nahas D, Wu C, Montefiori D, Shiver JW, Pessi A, Kim PS.

Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10655-60. doi: 10.1073/pnas.1004261107. Epub 2010 May 18.


Oligomers of beta-amyloid are sequestered into and seed new plaques in the brains of an AD mouse model.

Gaspar RC, Villarreal SA, Bowles N, Hepler RW, Joyce JG, Shughrue PJ.

Exp Neurol. 2010 Jun;223(2):394-400. doi: 10.1016/j.expneurol.2009.09.001. Epub 2009 Sep 8.


Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys.

Fu TM, Grimm KM, Citron MP, Freed DC, Fan J, Keller PM, Shiver JW, Liang X, Joyce JG.

Vaccine. 2009 Feb 25;27(9):1440-7. doi: 10.1016/j.vaccine.2008.12.034. Epub 2009 Jan 13.


Short communication: In vitro synergy between peptides or neutralizing antibodies targeting the N- and C-terminal heptad repeats of HIV Type 1 gp41.

Hrin R, Montgomery DL, Wang F, Condra JH, An Z, Strohl WR, Bianchi E, Pessi A, Joyce JG, Wang YJ.

AIDS Res Hum Retroviruses. 2008 Dec;24(12):1537-44. doi: 10.1089/aid.2008.0129. Review.


Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus.

Fu TM, Freed DC, Horton MS, Fan J, Citron MP, Joyce JG, Garsky VM, Casimiro DR, Zhao Q, Shiver JW, Liang X.

Virology. 2009 Mar 1;385(1):218-26. doi: 10.1016/j.virol.2008.11.035. Epub 2008 Dec 13.


An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions.

Joyce JG, Krauss IJ, Song HC, Opalka DW, Grimm KM, Nahas DD, Esser MT, Hrin R, Feng M, Dudkin VY, Chastain M, Shiver JW, Danishefsky SJ.

Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15684-9. doi: 10.1073/pnas.0807837105. Epub 2008 Oct 6.


Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons.

Shughrue PJ, Acton PJ, Breese RS, Zhao WQ, Chen-Dodson E, Hepler RW, Wolfe AL, Matthews M, Heidecker GJ, Joyce JG, Villarreal SA, Kinney GG.

Neurobiol Aging. 2010 Feb;31(2):189-202. doi: 10.1016/j.neurobiolaging.2008.04.003.


Fully synthetic carbohydrate HIV antigens designed on the logic of the 2G12 antibody.

Krauss IJ, Joyce JG, Finnefrock AC, Song HC, Dudkin VY, Geng X, Warren JD, Chastain M, Shiver JW, Danishefsky SJ.

J Am Chem Soc. 2007 Sep 12;129(36):11042-4. Epub 2007 Aug 21. No abstract available.


Solution state characterization of amyloid beta-derived diffusible ligands.

Hepler RW, Grimm KM, Nahas DD, Breese R, Dodson EC, Acton P, Keller PM, Yeager M, Wang H, Shughrue P, Kinney G, Joyce JG.

Biochemistry. 2006 Dec 26;45(51):15157-67. Epub 2006 Dec 6.


Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.

Chakraborty K, Durani V, Miranda ER, Citron M, Liang X, Schleif W, Joyce JG, Varadarajan R.

Biochem J. 2006 Nov 1;399(3):483-91.


Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I.

Bernier V, Stocco R, Bogusky MJ, Joyce JG, Parachoniak C, Grenier K, Arget M, Mathieu MC, O'Neill GP, Slipetz D, Crackower MA, Tan CM, Therien AG.

J Biol Chem. 2006 Aug 25;281(34):24704-12. Epub 2006 Jun 20.


The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease.

Catalano SM, Dodson EC, Henze DA, Joyce JG, Krafft GA, Kinney GG.

Curr Top Med Chem. 2006;6(6):597-608. Review.


A novel Staphylococcus aureus vaccine: iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model.

Kuklin NA, Clark DJ, Secore S, Cook J, Cope LD, McNeely T, Noble L, Brown MJ, Zorman JK, Wang XM, Pancari G, Fan H, Isett K, Burgess B, Bryan J, Brownlow M, George H, Meinz M, Liddell ME, Kelly R, Schultz L, Montgomery D, Onishi J, Losada M, Martin M, Ebert T, Tan CY, Schofield TL, Nagy E, Meineke A, Joyce JG, Kurtz MB, Caulfield MJ, Jansen KU, McClements W, Anderson AS.

Infect Immun. 2006 Apr;74(4):2215-23.


A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection.

Hepler RW, Kelly R, McNeely TB, Fan H, Losada MC, George HA, Woods A, Cope LD, Bansal A, Cook JC, Zang G, Cohen SL, Wei X, Keller PM, Leffel E, Joyce JG, Pitt L, Schultz LD, Jansen KU, Kurtz M.

Vaccine. 2006 Mar 6;24(10):1501-14. Epub 2005 Oct 21.


Progress towards the development of a HIV-1 gp41-directed vaccine.

McGaughey GB, Barbato G, Bianchi E, Freidinger RM, Garsky VM, Hurni WM, Joyce JG, Liang X, Miller MD, Pessi A, Shiver JW, Bogusky MJ.

Curr HIV Res. 2004 Apr;2(2):193-204. Review.


Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus.

Joyce JG, Abeygunawardana C, Xu Q, Cook JC, Hepler R, Przysiecki CT, Grimm KM, Roper K, Ip CC, Cope L, Montgomery D, Chang M, Campie S, Brown M, McNeely TB, Zorman J, Maira-LitrĂ¡n T, Pier GB, Keller PM, Jansen KU, Mark GE.

Carbohydr Res. 2003 Apr 22;338(9):903-22.


HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.

McGaughey GB, Citron M, Danzeisen RC, Freidinger RM, Garsky VM, Hurni WM, Joyce JG, Liang X, Miller M, Shiver J, Bogusky MJ.

Biochemistry. 2003 Mar 25;42(11):3214-23.


Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design.

Joyce JG, Hurni WM, Bogusky MJ, Garsky VM, Liang X, Citron MP, Danzeisen RC, Miller MD, Shiver JW, Keller PM.

J Biol Chem. 2002 Nov 29;277(48):45811-20. Epub 2002 Sep 16. Erratum in: J Biol Chem. 2003 Feb 14;278(7):5492..


Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.

Shiver JW, Fu TM, Chen L, Casimiro DR, Davies ME, Evans RK, Zhang ZQ, Simon AJ, Trigona WL, Dubey SA, Huang L, Harris VA, Long RS, Liang X, Handt L, Schleif WA, Zhu L, Freed DC, Persaud NV, Guan L, Punt KS, Tang A, Chen M, Wilson KA, Collins KB, Heidecker GJ, Fernandez VR, Perry HC, Joyce JG, Grimm KM, Cook JC, Keller PM, Kresock DS, Mach H, Troutman RD, Isopi LA, Williams DM, Xu Z, Bohannon KE, Volkin DB, Montefiori DC, Miura A, Krivulka GR, Lifton MA, Kuroda MJ, Schmitz JE, Letvin NL, Caulfield MJ, Bett AJ, Youil R, Kaslow DC, Emini EA.

Nature. 2002 Jan 17;415(6869):331-5.


An enhanced and scalable process for the purification of SIV Gag-specific MHC tetramer.

Grimm KM, Trigona WL, Heidecker GJ, Joyce JG, Fu TM, Shiver JW, Keller PM, Cook JC.

Protein Expr Purif. 2001 Nov;23(2):270-81.


Antibody, cytokine and cytotoxic T lymphocyte responses in chimpanzees immunized with human papillomavirus virus-like particles.

Palker TJ, Monteiro JM, Martin MM, Kakareka C, Smith JF, Cook JC, Joyce JG, Jansen KU.

Vaccine. 2001 Jun 14;19(27):3733-43.


Purification of virus-like particles of recombinant human papillomavirus type 11 major capsid protein L1 from Saccharomyces cerevisiae.

Cook JC, Joyce JG, George HA, Schultz LD, Hurni WM, Jansen KU, Hepler RW, Ip C, Lowe RS, Keller PM, Lehman ED.

Protein Expr Purif. 1999 Dec;17(3):477-84.


The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes.

Joyce JG, Tung JS, Przysiecki CT, Cook JC, Lehman ED, Sands JA, Jansen KU, Keller PM.

J Biol Chem. 1999 Feb 26;274(9):5810-22.


Expression and purification of recombinant tick anticoagulant peptide (Y1W/D10R) double mutant secreted by Saccharomyces cerevisiae.

Cook JC, Schultz LD, Huang J, George HA, Herber WK, Ip C, Joyce JG, Mao SS, Markus HZ, Miller WJ, Sardana MK, Lehman ED.

Protein Expr Purif. 1998 Aug;13(3):291-300.


Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast.

Lowe RS, Brown DR, Bryan JT, Cook JC, George HA, Hofmann KJ, Hurni WM, Joyce JG, Lehman ED, Markus HZ, Neeper MP, Schultz LD, Shaw AR, Jansen KU.

J Infect Dis. 1997 Nov;176(5):1141-5.


Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae.

Hofmann KJ, Cook JC, Joyce JG, Brown DR, Schultz LD, George HA, Rosolowsky M, Fife KH, Jansen KU.

Virology. 1995 Jun 1;209(2):506-18.


Chromatographic separation of low-molecular-mass recombinant proteins and peptides on Superdex 30 prep grade.

Joyce JG, Cook JC, Przysiecki CT, Lehman ED.

J Chromatogr B Biomed Appl. 1994 Dec 9;662(2):325-34.


Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae.

Lehman ED, Joyce JG, Bailey FJ, Markus HZ, Schultz LD, Dunwiddie CT, Jacobson MA, Miller WJ.

Protein Expr Purif. 1993 Jun;4(3):247-55.


A novel process for the large-scale purification of recombinant tick anticoagulant peptide using perfusion chromatography.

Lehman ED, Joyce JG, Freymeyer DK 2nd, Bailey FJ, Herber WK, Miller WJ.

Biotechnology (N Y). 1993 Feb;11(2):207-12.


Characterization of recombinant antistasin secreted by Saccharomyces cerevisiae.

Przysiecki CT, Joyce JG, Keller PM, Markus HZ, Carty CE, Hagopian A, Sardana MK, Dunwiddie CT, Ellis RW, Miller WJ, et al.

Protein Expr Purif. 1992 Jun;3(3):185-95.


Large-scale purification and characterization of recombinant tick anticoagulant peptide.

Lehman ED, Schaefer TF, Przysiecki CT, Joyce JG, Bailey FJ, Schulman CA, Burke CJ, Ramjit HG, Miller WJ.

J Chromatogr. 1992 Feb 14;574(2):225-35.


Carcinoma of the bladder treated by partial or total cystectomy.

Joyce JG, Lenaghan D.

Aust N Z J Surg. 1980 Dec;50(6):603-9.


Abnormal bleeding after prostatectomy: illustrative cases and review of management.

O'Sullivan EF, Joyce JG.

Med J Aust. 1972 Nov 18;2(21):1165-9. No abstract available.


Supplemental Content

Loading ...
Support Center